198 related articles for article (PubMed ID: 33888701)
1. Quantitative imaging of intracellular nanoparticle exposure enables prediction of nanotherapeutic efficacy.
Yin Q; Pan A; Chen B; Wang Z; Tang M; Yan Y; Wang Y; Xia H; Chen W; Du H; Chen M; Fu C; Wang Y; Yuan X; Lu Z; Zhang Q; Wang Y
Nat Commun; 2021 Apr; 12(1):2385. PubMed ID: 33888701
[TBL] [Abstract][Full Text] [Related]
2. A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting.
Luo Y; Huang L; Yang Y; Zhuang X; Hu S; Ju H; Yu BY; Tian J
Theranostics; 2017; 7(5):1245-1256. PubMed ID: 28435462
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin-mediated biomimetic synthesis of paramagnetic O
Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B
Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236
[TBL] [Abstract][Full Text] [Related]
4. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
Chen Q; Liu Z
Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
[TBL] [Abstract][Full Text] [Related]
5. Reporter nanoparticle that monitors its anticancer efficacy in real time.
Kulkarni A; Rao P; Natarajan S; Goldman A; Sabbisetti VS; Khater Y; Korimerla N; Chandrasekar V; Mashelkar RA; Sengupta S
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2104-13. PubMed ID: 27036008
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
7. Nanotherapeutics for Antimetastatic Treatment.
Yang F; Zhao Z; Sun B; Chen Q; Sun J; He Z; Luo C
Trends Cancer; 2020 Aug; 6(8):645-659. PubMed ID: 32448754
[TBL] [Abstract][Full Text] [Related]
8. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
10. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
[TBL] [Abstract][Full Text] [Related]
11. Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by monochromatic ratiometric imaging.
Yan Y; Chen B; Yin Q; Wang Z; Yang Y; Wan F; Wang Y; Tang M; Xia H; Chen M; Liu J; Wang S; Zhang Q; Wang Y
Nat Commun; 2022 Apr; 13(1):2004. PubMed ID: 35422063
[TBL] [Abstract][Full Text] [Related]
12. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.
Goos JACM; Cho A; Carter LM; Dilling TR; Davydova M; Mandleywala K; Puttick S; Gupta A; Price WS; Quinn JF; Whittaker MR; Lewis JS; Davis TP
Theranostics; 2020; 10(2):567-584. PubMed ID: 31903138
[TBL] [Abstract][Full Text] [Related]
13. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.
Kang SJ; Jeong HY; Kim MW; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Park YS
Nanoscale; 2018 Nov; 10(41):19338-19350. PubMed ID: 30307008
[TBL] [Abstract][Full Text] [Related]
15. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
[TBL] [Abstract][Full Text] [Related]
16. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.
Dai Y; Xu C; Sun X; Chen X
Chem Soc Rev; 2017 Jun; 46(12):3830-3852. PubMed ID: 28516983
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
19. Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution.
Strittmatter N; Moss JI; Race AM; Sutton D; Canales JR; Ling S; Wong E; Wilson J; Smith A; Howes C; Bunch J; Barry ST; Goodwin RJA; Ashford MB
Theranostics; 2022; 12(5):2162-2174. PubMed ID: 35265205
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
